Author: BlackMask Financial

Posted on

COVID SCIENCE-mRNA vaccines spur lymph nodes for longer-term protection

March 15 (Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. mRNA vaccines spur lymph nodes for longer-term protection. Along with inducing antibodies for immediate defense, mRNA vaccines against COVID-19 also stimulate the lymph nodes to generate immune cells that provide protection over the long term, a new study confirms. The early wave of antibodies are generated by B cells called plasmablasts.

In healthy volunteers, blood tests showed that two doses of the Pfizer/BioNTech vaccine induced “a strong plasmablast response,” said coauthor Ali Ellebedy of Washington University School of Medicine in St. Louis.

The immune cells that will produce antibodies upon exposure to the virus in years to come – called memory B cells – are generated by germinal center B cells found only in lymph nodes near vaccine injection sites, his team explained in a paper currently undergoing peer review for possible publication in a Nature journal. In repeated biopsies of volunteers’ lymph nodes, “we saw a robust germinal center response,” Ellebedy said. The responses lasted at least seven weeks, “with no sign of cooling down anytime soon,” he added. “While we do not have long-term samples yet, it is safe to assume given the magnitude and persistence of the germinal center reaction that those individuals will develop a durable immune response” to mRNA vaccines. Moderna Inc’s vaccine also uses mRNA technology. (https://bit.ly/3tnAiYw)

Throat swab test accuracy may vary by time of day

The accuracy of gold-standard PCR tests of nasopharyngeal swab samples may vary by time of day, new data suggest. Researchers analyzed 31,094 tests performed in symptomatic and asymptomatic individuals at 127 testing sites, including 2,438 tests that showed COVID-19. In a paper posted on Saturday on medRxiv ahead of peer review, they report tests were most likely to be positive around 2 p.m. – and the proportion of positive tests in the early afternoon was two-fold higher than the lowest proportion seen at other times of the day. The study “suggests people may be more contagious at certain times of the day and it raises questions about whether tests for SARS-CoV-2 may be less accurate when they are collected between late evening and early morning,” said coauthor Dr. Candace McNaughton of Vanderbilt University. “If our findings are confirmed, clinicians and public health teams could focus their efforts on lowering the risk of viral spread during times of peak viral shedding,” she said. That could entail emphasizing mid-day to early-afternoon masking at home while isolating, or encouraging early morning shopping for vulnerable populations. “There may be greater benefit in repeat testing if a negative test was collected when viral shedding is generally less,” McNaughton said. (https://bit.ly/2NjcZiY)

Surgery delay advised after COVID-19

When possible, surgery should be delayed for at least seven weeks after infection with the new coronavirus, and patients who still have symptoms at that point may benefit from further delay, researchers advise in Anaesthesia. They reviewed data on 140,231 surgery patients from 116 countries, including 3,127 with a history of COVID-19. The mortality rate at 30 days after surgery was 1.4% in patients who never had COVID-19. It was 9.1% among patients diagnosed within two weeks before surgery, 6.9% among those diagnosed within 3 to 4 weeks, and 5.5% when the diagnosis was made 5 to 6 weeks preoperatively. The mortality rate came down to 2% when at least 7 weeks had elapsed between diagnosis and surgery. For patients with ongoing symptoms, the 30-day mortality rate was 6% even after a 7-week delay, researchers found. After adjusting for other risk factors, the odds of death were increased 3.6-to-4.1-fold in patients having surgery within six weeks after a COVID-19 diagnosis. “Patients with ongoing symptoms at least seven weeks from diagnosis may benefit from further delay” of their surgery, the researchers said. Nick Note: The only vaccines to get are the mRNA. We do not know the long term affects of these vaccines. I based my decision to get the Pfizer vaccine by the fact that we have data going back over 5 years by these vaccines given for the Zika virus and a rabies vaccine. So we do have some history. Look we are getting to be the old geysers we use to laugh at when we were twenty somethings. And the risk of the coronal virus in baby boomers is extreme. So we have no choice as i see it but to take the path that represents the least risk. I mush rather risk the vaccine then the coronavirus……Below is a link to one of the best studies going back to 2016 on the mRNA technology  used to fight Zika

https://www.nature.com/articles/nature21428

Posted on

Biden: 100M relief checks to be distributed over next 10 days

  • Biden pledged to get 100 million shots in arms and 100 million checks in pockets in the next 10 days.
  • As of Friday, the US had already administered 100 million COVID-19 vaccine doses.
  • Stimulus checks from the American Rescue Plan are starting to hit Americans’ bank accounts.

President Joe Biden said on Monday that the US was on track to meet two big goals in the coming 10 days: administering over 100 million COVID-19 vaccine doses, and sending 100 million stimulus checks. “Over the next 10 days, we’ll reach two giant goals. The first is 100 million shots in people’s arms will have been completed in the next 10 days, and 100 million checks in people’s pockets,” Biden said during a speech at the White House.

“Shots in arms and money in pockets – that’s important,” he added.

The US hit the first goal on Friday, surpassing the benchmark of 100 million shots administered. The figure covers doses in Pfizer-BioNTech’s and Moderna’s two-shot regimens and Johnson & Johnson’s one-shot vaccine. As of Monday, 71 million Americans had received at least one vaccine dose, including 38.3 million who have been fully vaccinated, according to the Centers for Disease Control and Prevention. That means one in five US adults has gotten at least one vaccine dose. The Biden administration has recently made significant investments in the US’s vaccine supply. It plans to procure enough vaccines for all American adults by the end of May. On Thursday, in his first prime-time address to the American people, the president announced that the administration would direct states and localities to make every adult eligible to get vaccinated by May 1. Biden also confirmed that he would appoint the former national economic advisor Gene Sperling to oversee the implementation of the American Rescue Plan, the sweeping $US1.9 ($2) trillion COVID-19 relief package that Biden signed into law on Thursday. The bill includes $US1,400 ($1,811) stimulus checks for people below certain income thresholds and other direct aid for families. It followed the bill signed into law by President Donald Trump in December that delivered $US600 ($776) checks to eligible individuals. “We’re just getting started,” Biden said on Monday. “By the time all the money is distributed, 85% of American households will have gotten $US1,400 ($1,811) rescue checks.” Some people have already received their payments, and millions more Americans are set to get theirs in their bank accounts on Wednesday. People can check on the status of their check with the IRS’s “Get My Payment” tool. Nick Note: Their are so many calls by people checking on their checks that the IRS system crashed as reported by our Downdetector service. Also the Redditt web sight a favorite of the new blood millennial traders was overwhelmed. All this means is that people are going crazy looking for their happy checks. And they cannot wait to get into the free money the stock marker has to give.

Posted on

US closes higher, Dow, S&P reach new records

(Reuters) – Wall Street climbed on Monday, with the S&P 500 closing at a record high, as investors awaited cues from the Federal Reserve this week amid caution over rising borrowing costs spurred by massive fiscal stimulus. In a concrete sign that the worst of the damage from the coronavirus pandemic may be over for the airline industry, Delta Air Lines, Southwest Airlines and JetBlue Airways said leisure bookings were rising. The S&P 1500 airlines index jumped to a one-year high, while other travel-related stocks, including Carnival Corp, Wynn Resorts and MGM Resorts also gained. Most of the 11 major S&P sector indexes rose, led by utilities and real estate. Major stock indexes on Friday logged their best week in six after mass vaccinations and congressional approval of a $1.9 trillion aid bill accelerated demand for stocks expected to outperform as the economy reopens, such as banks, energy, materials companies. The Russell growth index outperformed the Russell value index in a modest reversal of investors’ recent trend away from technology and other high-growth stocks.  The DJIA was up 0.53% at the closing bell. McDonald’s Corp. was the best performer on the index, rising 3.82%. The S&P 500 gained 0.65% with United Airlines Holdings Inc. climbing 8.26%. The Nasdaq 100 jumped 1.12%, as NXP Semiconductors N.V. surged 8.84%. Nick Note: The Black Jack trade its a killer. THe rocket is ready to launch…….

Posted on

EU Starts Legal Action Vs UK As Brexit Deal Delays Make Split Nastier by the Day

The divorce between the U.K. and the EU is turning nastier by the day. The European Union said Monday it is starting legal action against the United Kingdom, arguing the former member does not respect the conditions of the Brexit withdrawal agreement and is violating international law. The 27-nation EU is objecting to Britain unilaterally extending a grace period beyond Apr. 1 that applies to trade on the island of Ireland, where the EU and the United Kingdom share a land border and where a special trade system was set up as part of the Brexit divorce deal. “The recent measures once again set the U.K. on the path of a deliberate breach of its international law obligations and the duty of good faith that should prevail,” EU Vice President Maros Sefcovic wrote to his U.K. counterpart David Frost. It marks a further worsening of relations between the two sides since a divorce transition period ended on Jan. 1. Disputes have ranged from fights over vaccines, to the full diplomatic recognition of the EU in Britain and now again the terms of the divorce agreement. On March 3 the U.K. decided to unilaterally extend a grace period until October on checks for goods moving between Britain and Northern Ireland. Northern Ireland is part of the United Kingdom but remained part of the EU’s single market for goods after Brexit to avoid a hard border that could revive sectarian violence. That means that products arriving from Britain face EU import regulations. A U.K. government spokesperson said it will respond to the EU Commission “in due course,” insisting the measures are temporary and aimed at reducing disruptions in Northern Ireland. Nick Note: The kid gloves have come off and the brass knuckles are on. This divorce has just gotten very nasty. You should see the mess the UK’EU finacial system is in….. Fortunately we saw this comming and picked the winner ENGLAND.

 

Posted on

See how they RUN

Canaccord Genuity Chief Market Strategist Tony Dwyer breaks down his outlook for the economic recovery and stock market with Yahoo Finance’s Myles Udland and Brian Sozzi.

Margaret Patel, senior portfolio manager at Wells Fargo Asset Management, and Ernesto Ramos, U.S. CIO at BMO Global Asset Management, join “Squawk on the Street” to discuss moves in the markets.

https://youtu.be/SC-g5t2IQ8U

RBC Capital Markets Equity Derivatives Strategist Amy Wu Silverman speaks with Bloomberg’s Alix Steel and Guy Johnson about effect of rising yields on the equity market and how U.S. stimulus checks may boost options on “Bloomberg Markets:”.

Dow hits record high at open as Nasdaq moves between gains and losses

Mohamed El-Erian, economic advisor at Allianz and Gramercy and president at Queens College, Cambridge, joined “Squawk Box” on Monday to discuss the markets ahead of a new trading week as Americans receive their latest stimulus checks.

Investor Ann Winblad on where she sees Big Tech stocks heading

Nick Note: See how they are scratching their collective asses and starting to figure it out

 

Posted on

Repeating: Masters of Equities Universe Are Unfazed by Spike in Bond Yields

(Bloomberg) — The recent rise in interest rates triggered a bout of volatility, but it’s not making the pros in the stock market run for the hills just yet.

Some of the world’s biggest fund managers say equities can persevere and continue rallying through the rise in government bond yields. They are focusing instead on prospects for a powerful economic and profit recovery.

In an informal Bloomberg News survey of more than 50 market players, most respondents including State Street Global Advisors and JPMorgan Asset Management said they’re monitoring the pace of the ascent in yields — and the reasons for it — rather than awaiting a particular level that will mark a breaking point for stocks. As long as central banks stick to accommodative policies, the equity bull run can power ahead, these investors say. “Absent a shift in central banks’ thinking, we don’t think yields will rise to a level where it broadly hurts equities,” said Hugh Gimber, a London-based global market strategist at JPMorgan Asset Management. “Provided the Fed sticks to guidance, and remains comfortable, willing to look through any temporary spike in inflation, I don’t see an environment where yields are rising in a way that’s problematic for equities broadly.” The surge in government bond yields over the past month helped fuel an exit from the frothier parts of the market such as technology and defensive shares, leading to a dip of as much 11% in the Nasdaq 100. But the vaccination push in major economies and bets on a recovery in economic growth as well as consumer spending are filling equity bulls with confidence that they can keep reaping returns despite higher interest rates. At the same time, the pick-up in yields and the more than 70% rally in stocks from pandemic lows are pushing fund managers to become more selective. The likes of Manulife Investment Management and HSBC Asset Management say that, while this isn’t the time to exit equities, the selloff in bonds will accelerate the rotation out of the more expensive growth parts of the market and into cheaper and laggard equities that can benefit from the economic recovery. “If rates were rising from a normal range, tech stocks would’ve been fine, but not true when the valuations are what they have been,” said Dave King, a Boston-based portfolio manager at Columbia Threadneedle Investments. “Potential reopening, coinciding with the rise in yields as well as other factors, were positive for the stocks that people didn’t like too much last year, whether it’s banks or energy.” The energy sector is the best performer in the MSCI World this year, rising about 30%, while financials are next with a 14% gain. More defensive and rates-dependent sectors, such as consumer staples and utilities, are both in the red. Cult stocks that have been investors’ favorites throughout the pandemic have also had a harsh few weeks. Tesla Inc. was down as much as 36% from its January peak before recouping some of its losses last week. Even market stalwart Apple Inc., the biggest U.S. stock, crashed as much as 19% from its record high. This environment could also mark a shift from U.S. stocks to other international equities, such as Europe and emerging markets, that have higher exposure to value sectors. Having lagged the S&P 500 during last year’s rally from the March lows, the Stoxx Europe 600 is outpacing the American benchmark so far in 2021. “The risk of an equity market correction driven by higher yields is highest in the U.S.,” said Joost van Leenders, an Amsterdam-based senior investment strategist at Kempen Capital Management. “The U.S. economy has recovered faster than the European economy, and another major fiscal stimulus bill has just been approved. Inflationary pressure in Europe looks minimal. From a style perspective, growth is more at risk than value. This also means Europe may benefit relative to the U.S.” Investors who are watching out for a particular Treasury yield level that can significantly hurt global equities pointed to a range between 2% and 3% for 10-year bonds.

“It’s important to remember that historically, rising yields have been consistent with rising markets, because both are driven by growth, and we think that will remain the case this time,” said Mark Haefele,

chief investment officer at UBS Global Wealth Management. At the same time, he added that “yields above 2.25-2.5%, if not accompanied by an improvement in the long-term earnings growth outlook and lower risk premia, would start to make current equity valuations look more challenged.” The pause in the bond market selloff in the middle of the week last week showed how quickly stocks and growth sectors can come rushing back. The Nasdaq 100 on Tuesday surged 4% for its biggest jump since November, signaling that appetite for tech names remains strong. “If the rise in bond yields is too quick or too high, it’s a negative for equity valuations. However, if controlled and modest over time, equities can absorb the adjustment reasonably well,” said Nathan Thooft, Boston-based global head of asset allocation at Manulife Investment Management. “Especially if the reason for higher rates is better growth rather than just higher inflation.” Nick Note: How many times can i tell you. The Hedge Gunds shorted the shit out of this market and it is gained back a lot of its former glory. So much so that indicators tell us they are under water. Now the horror show begins for them…. A billion little piss ants are about to go into this marekt and eat the elephants…… Bon Apitite,

Posted on

S&P 500 subdued as focus turns to Fed

* Eli Lily drops after ‘mixed’ data from mid-stage trial

* Southwest, JetBlue signal recovery in leisure bookings

* Indexes: Dow up 0.1%, S&P flat, Nasdaq dips 0.1% (Updates to market open)

March 15 (Reuters) – The S&P 500 paused on Monday below an all-time high as investors awaited cues from the Federal Reserve’s meeting this week amid caution over rising borrowing costs spurred by massive fiscal stimulus. Delta Air Lines, Southwest Airlines and JetBlue Airways said leisure bookings are rising and offered some of the first concrete signs that the worst may be over for the airline industry. The S&P 1500 airlines index jumped about 3.8% to a one-year high, while planemaker Boeing Co added about 2%. Other travel-related stocks including Carnival Corp, Wynn Resorts and MGM Resorts gained between 3% and 5%. Wall Street’s main indexes on Friday logged their best week in six as approval of a $1.9 trillion relief package and mass vaccinations fueled demand for economy-linked stocks such as banks, energy, materials at the cost of high-growth tech names. The major U.S. stock indexes were roiled in recent weeks as a spike in longer-dated U.S. bond yields due to fears of an increase in inflation and, in response, a tapering of the Fed’s easy monetary policy worried investors. “The U.S. economy looks in a better shape than most other developed economies,” said Hussein Sayed, chief market strategist at FXTM. “Despite the rosier economic outlook, this week’s Fed meeting is expected to be absent of major policy changes.” At the end of Fed’s two-day meeting on Wednesday, policymakers are expected to forecast that the U.S. economy will grow in 2021 at the fastest rate in decades while reiterating their dovish stance for the foreseeable future. The yields on benchmark 10-year Treasuries hovered near their 13-month high at 1.61%, slightly lower than its peak of 1.64% hit on Friday. At 9:47 a.m. ET, the Dow Jones Industrial Average rose 87.51 points, or 0.27%, to 32,866.15, the S&P 500 gained 0.29 points, or 0.01%, to 3,943.63 and the Nasdaq Composite lost 6.81 points, or 0.05%, to 13,313.11. Five of the major S&P sectors were lower, with financials and energy leading losses. Tesla Inc added “Technoking of Tesla” to billionaire Chief Executive Elon Musk’s list of official titles in a formal regulatory filing that also named finance chief Zachary Kirkhorn “Master of Coin”. Tesla’s shares were nearly flat. Eli Lilly and Co shares slumped about 8.5% after “mixed” results from the drugmaker’s mid-stage trial testing its experimental drug to treat Alzheimer’s cast a doubt on the chances for the drug’s accelerated approval, according to analysts. Advancing issues outnumbered decliners by a 1.2-to-1 ratio on the NYSE and a 1-to-1 ratio on the Nasdaq. The S&P 500 posted 59 new 52-week highs and no new low, while the Nasdaq recorded 239 new highs and six new lows.

Posted on

Regular booster vaccines are the future in battle with COVID-19 virus, Peacock says

CAMBRIDGE, England (Reuters) – Regular booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain’s effort to sequence the virus’s genomes told Reuters. The novel coronavirus, which has killed 2.65 million people globally since it emerged in China in late 2019, mutates around once every two weeks, slower than influenza or HIV, but enough to require tweaks to vaccines. Sharon Peacock, who heads COVID-19 Genomics UK (COG-UK) which has sequenced half of all the novel coronavirus genomes so far mapped globally, said international cooperation was needed in the “cat and mouse” battle with the virus

“We have to appreciate that we were always going to have to have booster doses; immunity to coronavirus doesn’t last forever,” Peacock told Reuters at the non-profit Wellcome Sanger Institute’s 55-acre campus outside Cambridge.

“We already are tweaking the vaccines to deal with what the virus is doing in terms of evolution – so there are variants arising that have a combination of increased transmissibility and an ability to partially evade our immune response,” she said. Peacock said she was confident regular booster shots – such as for influenza – would be needed to deal with future variants but that the speed of vaccine innovation meant those shots could be developed at pace and rolled out to the population. COG-UK was set up by Peacock, a professor at Cambridge, exactly a year ago with the help of the British’s government’s chief scientific adviser, Patrick Vallance, as the virus spread across the globe to Britain. The consortium of public health and academic institutions is now the world’s deepest pool of knowledge about the virus’s genetics: At sites across Britain, it has sequenced 346,713 genomes of the virus out of a global effort of around 709,000 genomes. On the intellectual frontline at the Wellcome Sanger Institute, hundreds of scientists – many with PhDs, many working on a voluntary basis and some listening to heavy metal or electronic beats – work seven days a week to map and then search the virus’s growing family tree for patterns of concern. Wellcome Sanger Institute has sequenced over half of the UK total sequenced genomes of the virus after processing 19 million samples from PCR tests in a year. COG-UK is sequencing around 30,000 genomes per week – more than the UK used to do in a year.

Three main coronavirus variants – which were first identified in Britain (known as B.1.1.7), Brazil (known as P1)and South Africa (known as B.1.351) – are under particular scrutiny.

Peacock said she was most worried about B.1.351. “It is more transmissible, but it also has a change in a gene mutation, which we refer to as E484K, which is associated with reduced immunity – so our immunity is reduced against that virus,” Peacock said. With 120 million cases of COVID-19 around the world, it is getting hard to keep track of all the alphabet soup of variants, so Peacock’s teams are thinking in terms of “constellations of mutations.” “So a constellation of mutations would be like a leaderboard if you like – which mutations in the genome that we’re particularly concerned about, the E484K is must be one of the top of the leaderboard,” she said. “So we’re developing our thinking around that leaderboard to think, regardless of the background and lineage, about what mutations or constellation of mutations are going to be important biologically and different combinations that may have slightly different biological effects.” Peacock, though, warned of humility in the face of a virus that has brought so much death and economic destruction. “One of the things that the virus has taught me is that I can be wrong quite regularly – I have to be quite humble in the face of a virus that we know very little about still,” she said. “There may be a variant out there that we haven’t even discovered yet.” There will, though, be future pandemics. “I think its inevitable that we will have another virus emerge that is of concern. What I hope is that having learned what we have in this global pandemic, that we will be better prepared to detect it and contain it.” Nick  Note: Get the Pfizer vaccines… you can ease up a bit… But do not take stupid chances like getting drunk at the tittie bar. How about we stick with our vaccinated kids and grand kids and not take unnecessary changes. Kids can come back to the house. If everyone is vaccinated … ugly mask off. Look none of us are spring chickens. I am sure we went overboard…. SO. I have lost many people who went underboard…….. Its my sworn mission in life to make you wealthier and healthier. We survived the corona virus….SO FAR!. And i will use my tools to keep track of the mutations which will surely come. Look I am not sure of our internet connection in heaven… So your just going to have to stay with me here….. AND we are in what may be our greatest trade ever…. THe Black Jack trade…. we get them when the count is high and we get them when the count is low….. How cool is that! 

Posted on

Yellen: COVID relief to help get economy back on track

  • Treasury Secretary Janet Yellen said Sunday that the US could see full employment next year.

  • The stimulus package will offer the support for that recovery, Yellen told ABC News on Sunday.
  • Full employment does not mean zero unemployment, but it would reflect a healthier economy.

The US could return to full employment in 2022, Treasury Secretary Janet Yellen said on Sunday, renewing her forecast now that the Biden administration’s coronavirus pandemic relief package has been signed into law. “I am hopeful that if we defeat the pandemic, that we can have the economy back near full employment next year,” Yellen said in an interview with “This Week” on ABC News. Yellen said last month that the US economy could see such a recovery, but that it would hinge on whether President Joe Biden’s bill – which includes direct payments for individuals, an expansion of the child tax credit, and funding for vaccine distribution and testing – was adopted. The bill passed the Senate earlier this month in a 50-49 vote, and the House last week in a 220-211 vote. It marked the administration’s first major win, and comes as millions of Americans are struggling as the coronavirus pandemic has devastated parts of the economy in the past year. The Trump administration passed relief packages last year, offering direct payments to taxpayers among other aid to individuals. “I believe there is enough support in this package to relieve suffering and to get the economy quickly back on track,” Yellen, the former head of the Federal Reserve who was confirmed in January as Treasury Secretary, said Sunday. “Full employment” does not mean a state of zero unemployment, but such conditions would reflect a US economy that is far healthier than where it is today as the unemployment rate remains at levels elevated compared to previous years. The Bureau of Labor Statistics said earlier this month in the latest jobs report that the US unemployment rate fell to 6.2% from 6.3%. Still, that figure does not capture the breadth of how many people are out of work. The U-6 unemployment rate, which the government defines as workers who are marginally attached to the labor force and others who are employed part-time, was 11.1% in February, the BLS said. Some on Wall Street are optimistic about what the relief package means for the economic recovery. Goldman Sachs economists told clients earlier this month that the US employment rate could drop to 4.1% by year-end thanks to a combination of the stimulus package and coronavirus vaccines rolling out. “Despite the surprising speed of recovery early on, we are still very far from a strong labor market whose benefits are broadly shared,” Federal Reserve Chair Jerome Powell said last month. Nick Note: The market is still not pricing in the explosive growth about to hit the stock market

Posted on

Ireland’s vaccine taskforce calls for halt in AZ vaccine rollout

European countries – including Denmark, Norway, Austria, Italy and Iceland – have suspended use of the Oxford-AstraZeneca jab after reports of blood clots in vaccinated people. The European Medicines Agency is now launching an investigation but at present there is no firm evidence to suggest the two are linked and incidents of clotting have not been reported in the UK. Denmark, Norway and Iceland have suspended the rollout of the vaccine, while Italy and Austria have stopped using a certain batch as a precaution. The Danish Health and Medicines Authority said the rollout out of the jab would be paused for at least 14 days while investigations are carried out. They did not say how many reports of blood clots there had been. “It is currently not possible to conclude whether there is a link. We are acting early, it needs to be thoroughly investigated,” Danish health minister Magnus Heunicke said on Twitter.

News Flash

The Irish National Immunisation Advisory Committee (NIAC) recommended on Sunday that the rollout of the COVID-19 vaccine developed by AstraZeneca and Oxford University be stopped temporarily. Ireland’s Deputy Chief Medical Officer Ronan Glynn stated that the decision was made due to reports of increased risk of blood clots in people inoculated with the jab, and backed by the findings of the Norwegian Medicines Agency. He underlined that no direct link has been found between the thrombosis risk and the vaccine administration, but added that NIAC called for “the temporary deferral of the COVID-19 vaccine AstraZeneca vaccination programme” on “the precautionary principle.” Søren Brostrøm, director of the National Board of Health, added: “It is important to emphasise that we have not opted out of the AstraZeneca vaccine, but that we are putting it on hold. Nick Note: From the start i warned about the DNA monkey vaccine fron Astra. You should ONLY get the Pfizer mRNA vaccine… And you need to GET IT NOW! After all Pfizer  did bring you the no dick millennials Viagra…..